A Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)
Clinical trial NCT04755244 · TERMINATED
Trial details
- NCT number
- NCT04755244
- Sponsor
- ALX Oncology Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-05
- Primary completion
- 2023-05-05
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.